Abstract:Xueming Yang, 1– 4, &ast Teng Xu, 1, 2, 4, &ast Xiaomeng Song, 1, 2, 4 Yunong Wu 1, 2, 4 1 Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 2 Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 3 Department of Stomatology, the Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China; 4 Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yunong Wu, Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, No. 1, Shanghai Road, Nanjing, Jiangsu, 210029, People's Republic of China, Tel +86-25-69593100, Email Background: Neuropilin-1 (NRP1) is a significant molecular structure that participates in many diseases progress including malignant tumors. However, its role in head and neck squamous cell carcinoma (HNSCC) remains to be uncovered. In this study, we determined the function of NRP1 as a crucial biomarker in proliferation, metastasis and immunosuppression in HNSCC. Methods: We collected samples of normal tissues (n = 18) and HNSCC tissues (n = 202) for immunohistochemical staining of NRP1 and evaluated its correlation to clinical prognostic characteristics. Furthermore, we enrolled 37 HNSCC patients received immune checkpoint blockade (ICB) treatment with defined therapeutic effects records. The biological process, signal pathways, and immune infiltration relevance to NRP1 were analyzed utilized transcriptome data from The Cancer Genome Atlas (TCGA). Results: The NRP1 protein expression was significantly upregulated in HNSCC tissue and was associated with T stage, N stage, histological differentiation, recurrence and NRP1 expression. The high expression of NRP1 indicated poor survival rate and was found to be an independent prognosis factor. Enrichment analysis showed that NRP1 was associated with cell adhesion, extracellular matrix organization, homophilic cell adhesion via plasma membrane in biological process and neuroactive ligand–receptor interaction, protein digestion and absorption, calcium signal pathways. Moreover, NRP1 mRNA level was found positively correlated to cancer associated fibroblast cells, Treg cells and macrophage/monocyte cells. Conclusion: NRP1 might be likely to develop into a potential immunoregulation target as well as a predictive biomarker in HNSCC immune treatment. Keywords: NRP1, head and neck squamous cell carcinoma, immunosuppression, prognosis, bioinformatics Head and neck cancer is identified as the 6th most common cancer worldwide and squamous cell carcinoma is the most common subtype accounting for approximately 95% in head and neck malignant lesions. 1 Though radical excision combined with postoperative adjuvant radiotherapy, the overall survival does not improve obviously over the past three decades. Apart from the traditional risk factors including smoking, alcohol 2,3 and human papillomavirus (HPV) infection, 4–6 immunosuppressive status and immune escape have been the hot research topics in recent years. 7,8 Although some drugs of immune checkpoint inhibitors have been approved by Food and Drug Administration (FDA), the responsivity is still at a low level. Therefore, the mechanisms of immunosuppressive status and immune escape are urgently to be elucidated. Neuropilin-1 (NRP1) is recognized as an important membrane-spanning protein that participates in many different signaling pathways. 9,10 It has been reported to involve in metastasis and radiation resistance in tumor progression. 11–13 Generally, NRP1 serves as the ligands or co-receptors including semaphorin family members and vascular endothelial growth factor (VEGF). 10,14 In breast cancer, up regulation of the VEGF/NRP1 is associated with the enhancement of epithelial-mesenchymal transition (EMT) process and the NF-κB, β-catenin signaling. 15,16 Recently, NRP1 was found to be an entrance of SARS-CoV-2 virus except ACE2 and simultaneously blocked NRP1/ACE2 and viral spike protein integration might be a valuable treatment option. 17 Tumor-infiltrating immune cell is an important component of tumor associated microenvironment (TAM). In normal tissue, the relative balance is maintained to keep the homeostasis of microenvironment, -Abstract Truncated-

Characterization and application of monoclonal antibodies against human NRP1

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

Preparation and characterization of a novel monoclonal antibody against human PD-1

SPECT Imaging of Neuropilin Receptor Type-1 Expression with 131I-Labeled Monoclonal Antibody.

Production and Characterization of a Monoclonal Antibody Against GRAM Domain-Containing Protein 1A

Targeting neuropilin-1 interactions is a promising anti-tumor strategy

Comprehensive Analysis of Novel Immune Checkpoint Neuropilins

Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer

Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver

Neuropilin-1, an immune checkpoint for controlling tumor-specific CD8 T-cell functions whose blockade improves anti-PD-1 immunotherapy

Agonistic Monoclonal Antibodies Potentiate Tumorigenic and Invasive Activities of Splicing Variant of the RON Receptor Tyrosine Kinase

Procaryotic Expression of Neuropilin-1 Fragments and Study on the Immunological Characteristics of Rabbit-Anti-Mouse Neuropilin-1 Antibody

Therapeutic Efficacy of a Novel Humanized Antibody-Drug Conjugate Recognizing Plexin-Semaphorin-integrin Domain in the RON Receptor for Targeted Cancer Therapy.

N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1

Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma

Neuropilin 1 (NRP1) is a Novel Tumor Marker in Hepatocellular Carcinoma

Role of NRP1 in Bladder Cancer Pathogenesis and Progression

Immune Inactivation by Neuropilin-1 Predicts Clinical Outcome and Therapeutic Benefit in Muscle-Invasive Bladder Cancer

Preparation and Characterization of Monoclonal Antibodies Against Nucleostemin, a Protein That Controls Cell Proliferation in Stem Cells and Cancer Cells